Guidelines about COVID-19
We've developed rapid guidelines with NHS England and NHS Improvement (NHSE&I) and a cross-speciality clinical group, supported by the specialist societies and royal colleges. These guidelines were developed quickly using a different approach to normal and we’re keeping them under review.
Managing symptoms and complications
- Acute kidney injury in hospital - NG175
- Acute myocardial injury - NG171
- Antibiotics for pneumonia in adults in hospital - NG173
- Critical care in adults - NG159
- Managing suspected or confirmed pneumonia in adults in the community - NG165
- Managing symptoms (including at the end of life) in the community - NG163
- Managing the long-term effects of COVID-19 - NG188
- Reducing the risk of venous thromboembolism in over 16s with COVID-19 - NG186
- Vitamin D - NG187.
Managing conditions that increase risk
- Children and young people who are immunocompromised - NG174
- Chronic kidney disease - NG176
- Community-based care of patients with chronic obstructive pulmonary disease (COPD) - NG168
- Cystic fibrosis - NG170
- Dermatological conditions treated with drugs affecting the immune response - NG169
- Gastrointestinal and liver conditions treated with drugs affecting the immune response - NG172
- Interstitial lung disease - NG177
- Rheumatological autoimmune, inflammatory and metabolic bone disorders - NG167
- Severe asthma - NG166.
Providing services during the pandemic
Rapid evidence summaries
These look at the safety and efficacy of COVID-19 treatments. We're working with the Medicines and Healthcare products Regulatory Agency (MHRA) to facilitate rapid review of information and advice.
Medtech innovation briefings
These innovative technologies have been identified as being potentially useful during the pandemic. They may also relieve pandemic related pressures on the healthcare system.
- CFHealthHub for managing cystic fibrosis during the COVID-19 pandemic - MIB219
- Cytokine adsorption devices for treating respiratory failure in people with COVID-19 - MIB217
- FebriDx for C-reactive protein and myxovirus resistance protein A testing - MIB224
- Lifelight First for monitoring vital signs - MIB213
- myCOPD for self-management of chronic obstructive pulmonary disease - MIB214
- URO17 for detecting bladder cancer - MIB250.
Resources to help restore services
Many of our resources could help the health and social care system return to more normal levels of non-COVID services and act on lessons learned during the first peak. We also have resources to help local partnerships tackle their priorities. For advice specific to your area, contact your local NICE field team.
Improving service delivery
- Suspected cancer: recognition and referral guideline - NG12
- Immunisations: reducing differences in uptake in under 19s - PH21
- Flu vaccination: increasing uptake - NG103
- Care and support of people growing older with learning disabilities - NG96
- Managing medicines in care homes - SC1
- Children and young people’s mental health - local partnership resource
- Improving transfer of care - local partnership resource
- Transforming maternity services - local partnership resource
- URO17 for detecting bladder cancer - MIB250
Managing long term conditions
- Mental health problems in people with learning disabilities: prevention, assessment and management - NG54
- Cardiovascular disease risk assessment and treatment - local partnership resource
- Detecting and treating hypertension - local partnership resource
- Preventing, detecting and managing diabetes - local partnership resource
- Adult common mental health problems - local partnership resource
- Respiratory conditions: reducing pressure on emergency hospital services - local partnership resource.
Clinical knowledge summaries
These are concise, accessible summaries of current evidence for primary care professionals.
We've added some information about COVID-19, which is largely based on guidance from Public Health England.
The RAPID-C19 initiative is a multi-agency approach that aims to get treatments for COVID-19 to NHS patients quickly and safely.
It also helps frontline staff in health and social care understand the options they have for treating affected patients.
Shared learning examples
These are case studies of how our guidance has been used in practice by health, local government and social care organisations. They are written by the organisations and shouldn't be interpreted as our endorsement of the approach taken.
- Supporting and Developing Community End of Life Care During the COVID-19 pandemic: An example of collaborative working
- A risk-stratified approach to planned cancer care during the COVID-19 pandemic: the Royal Marsden experience
- Delivering a paediatric elective surgery service during the COVID-19 pandemic
- Developing and implementing guidance for staff delegating clinical tasks to informal carers and relatives during the COVID-19 pandemic
- Maintaining a cancer service in the midst of the COVID-19 pandemic: A single centre experience
- COVID-19 ready rehabilitation for heart failure: REACH-HF can deliver.
NHSE&I specialty guides
The specialty guides are aimed at specialists working in hospitals in England during the pandemic. They aim to help departments continue essential care for patients while supporting the wider hospital and community to provide care for people with COVID-19.
More information and resources
A guide for internal guidance developers and external collaborators on assessing the quality of wider sources of data and evidence in our COVID-19 guidance.
A 3-stage approach to help anyone working on testing for COVID-19 to collect the best possible data and evidence while tests are being quickly developed and validated.
A guide to evidence collection for medicines, plus free scientific advice for researchers developing novel diagnostics or therapeutics for COVID-19.